Approved by the FDA earlier this year, the Alzheimer's therapy lecanemab is an antibody that reduces the buildup in the brain of a sticky peptide called amyloid-beta (Aβ), which is thought to be a main driver of the disease. ...
Sep 1, 2023
0
75
Scientists of the Global Cardiovascular Risk Consortium under the auspices of the Department of Cardiology at the University Heart & Vascular Center of the Medical Center Hamburg-Eppendorf (UKE) and the German Center for ...
Aug 28, 2023
0
89
A new dementia risk score, which draws on 11 mostly modifiable risk factors, identifies people at risk—from midlife onward—of developing the disease within the next 14 years, suggests a large long term study published ...
Aug 25, 2023
0
57
In a new study co-led by investigators at the United States Department of Veterans Affairs and Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, a global team of scientists conducted ...
Aug 24, 2023
0
29
In 2007, the teams of Massimo Terzolo and Martin Fassnacht published a study in the New England Journal of Medicine that provided evidence for the efficacy of mitotane in the prevention of recurrence in adrenocortical carcinoma. ...
Aug 24, 2023
0
2
In a large retrospective analysis using measurements of thousands of plasma proteins in primary and secondary event populations, scientists from deCODE genetics and collaborators from U.S., Denmark and Iceland, reported today ...
Aug 22, 2023
0
31
Older adults with more severe behavioral symptoms, including agitation, aggression, and disinhibition, are more likely to become divorced than those with less severe symptoms. However, increasing stages of dementia are associated ...
Aug 16, 2023
0
41
Two in five U.S. adults with or at risk for heart disease use smartphones or tablets to monitor their health, a new Yale study finds. But those at highest risk for heart disease are less likely to use technology to track ...
Aug 16, 2023
0
16
Between 7% and 15% of people in North America, between 5% and 9% of people in Europe, and between 1% and 5% of people in Asia suffer from kidney stones. Common symptoms are severe pain, nausea, vomiting, fever, chills, and ...
Aug 4, 2023
0
67
Genetic and neurobiological factors shape the development of eating disorders much earlier than previously thought, with evidence emerging in children as young as nine years old, Yale-led research reveals. The findings, researchers ...
Aug 3, 2023
1
57
